Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

State-of-the-art strategies for targeting protein–protein interactions by small-molecule inhibitors
Chunquan Sheng, Guoqiang Dong, Zhenyuan Miao, et al.
Chemical Society Reviews (2015) Vol. 44, Iss. 22, pp. 8238-8259
Closed Access | Times Cited: 148

Showing 1-25 of 148 citing articles:

Recent advances in the development of protein–protein interactions modulators: mechanisms and clinical trials
Haiying Lu, Qiaodan Zhou, Jun He, et al.
Signal Transduction and Targeted Therapy (2020) Vol. 5, Iss. 1
Open Access | Times Cited: 636
Orally Absorbed Cyclic Peptides
Daniel S. Nielsen, Nicholas E. Shepherd, Weijun Xu, et al.
Chemical Reviews (2017) Vol. 117, Iss. 12, pp. 8094-8128
Closed Access | Times Cited: 377
Drugging Ras GTPase: a comprehensive mechanistic and signaling structural view
Shaoyong Lu, Hyunbum Jang, Shuo Gu, et al.
Chemical Society Reviews (2016) Vol. 45, Iss. 18, pp. 4929-4952
Open Access | Times Cited: 175
Recent advances in targeting the “undruggable” proteins: from drug discovery to clinical trials
Xin Xie, Tingting Yu, Xiang Li, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 166
Advances of Artificial Intelligence in Anti-Cancer Drug Design: A Review of the Past Decade
Liuying Wang, Yongzhen Song, Hesong Wang, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 2, pp. 253-253
Open Access | Times Cited: 53
Allosteric Activation Dictates PRC2 Activity Independent of Its Recruitment to Chromatin
Chul‐Hwan Lee, Jia-Ray Yu, Sunil Kumar, et al.
Molecular Cell (2018) Vol. 70, Iss. 3, pp. 422-434.e6
Open Access | Times Cited: 119
Network analysis and in silico prediction of protein–protein interactions with applications in drug discovery
Yoichi Murakami, Lokesh P. Tripathi, Philip Prathipati, et al.
Current Opinion in Structural Biology (2017) Vol. 44, pp. 134-142
Closed Access | Times Cited: 105
Nrf2 activation through the inhibition of Keap1–Nrf2 protein–protein interaction
Sumi Lee, Longqin Hu
Medicinal Chemistry Research (2020) Vol. 29, Iss. 5, pp. 846-867
Open Access | Times Cited: 96
Emerging roles of allosteric modulators in the regulation of protein‐protein interactions (PPIs): A new paradigm for PPI drug discovery
Duan Ni, Shaoyong Lu, Jian Zhang
Medicinal Research Reviews (2019) Vol. 39, Iss. 6, pp. 2314-2342
Closed Access | Times Cited: 92
Small Molecule Inhibition of Ligand-Stimulated RAGE-DIAPH1 Signal Transduction
Michaele B. Manigrasso, Jinhong Pan, Vivek Rai, et al.
Scientific Reports (2016) Vol. 6, Iss. 1
Open Access | Times Cited: 91
Non-covalent Small-Molecule Kelch-like ECH-Associated Protein 1–Nuclear Factor Erythroid 2-Related Factor 2 (Keap1–Nrf2) Inhibitors and Their Potential for Targeting Central Nervous System Diseases
Jakob S. Pallesen, Kim T. Tran, Anders Bach
Journal of Medicinal Chemistry (2018) Vol. 61, Iss. 18, pp. 8088-8103
Closed Access | Times Cited: 88
A Gold Nanocage/Cluster Hybrid Structure for Whole‐Body Multispectral Optoacoustic Tomography Imaging, EGFR Inhibitor Delivery, and Photothermal Therapy
Chenyue Zhan, Yong Huang, Guifang Lin, et al.
Small (2019) Vol. 15, Iss. 33
Closed Access | Times Cited: 80
Computational approaches for the design of modulators targeting protein-protein interactions
Ashfaq Ur Rehman, Beenish Khurshid, Yasir Ali, et al.
Expert Opinion on Drug Discovery (2023) Vol. 18, Iss. 3, pp. 315-333
Open Access | Times Cited: 35
Fragment-based drug discovery supports drugging ‘undruggable’ protein–protein interactions
Zhi-Zheng Wang, Xing-Xing Shi, Guang-Yi Huang, et al.
Trends in Biochemical Sciences (2023) Vol. 48, Iss. 6, pp. 539-552
Closed Access | Times Cited: 27
New insights into protein–protein interaction modulators in drug discovery and therapeutic advance
Hossam Nada, Yongseok Choi, Sung-Do Kim, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 16
Multitargeted molecular docking and dynamics simulation of thymol-based chalcones against cancer protein markers: Synthesis, characterization, and computational study
Yassine Laamari, Abdoullah Bimoussa, Fawzi Mourad, et al.
Journal of Molecular Structure (2024) Vol. 1317, pp. 139116-139116
Closed Access | Times Cited: 14
Cyclic Peptide Keap1–Nrf2 Protein–Protein Interaction Inhibitors: Design, Synthesis, and In Vivo Treatment of Acute Lung Injury
Jihua Zou, Jianyu Yan, Yifei Lü, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 6, pp. 4889-4903
Closed Access | Times Cited: 10
Development of potent small-molecule inhibitors to drug the undruggable steroid receptor coactivator-3
Xianzhou Song, Jianwei Chen, Mingkun Zhao, et al.
Proceedings of the National Academy of Sciences (2016) Vol. 113, Iss. 18, pp. 4970-4975
Open Access | Times Cited: 83
Recent progress in Keap1-Nrf2 protein-protein interaction inhibitors
Yi Mou, Shuai Wen, Yuxiu Li, et al.
European Journal of Medicinal Chemistry (2020) Vol. 202, pp. 112532-112532
Closed Access | Times Cited: 69
Small molecules inhibiting Keap1–Nrf2 protein–protein interactions: a novel approach to activate Nrf2 function
Chunlin Zhuang, Zhongli Wu, Chengguo Xing, et al.
MedChemComm (2016) Vol. 8, Iss. 2, pp. 286-294
Open Access | Times Cited: 64
Tumor Inhibition Achieved by Targeting and Regulating Multiple Key Elements in EGFR Signaling Pathway Using a Self‐Assembled Nanoprodrug
Bowen Li, Xin Xie, Zelin Chen, et al.
Advanced Functional Materials (2018) Vol. 28, Iss. 22
Closed Access | Times Cited: 61
Anticancer drug discovery by targeting cullin neddylation
Qing Yu, Yihan Jiang, Yi Sun
Acta Pharmaceutica Sinica B (2019) Vol. 10, Iss. 5, pp. 746-765
Open Access | Times Cited: 59
Stabilized cyclic peptides as modulators of protein–protein interactions: promising strategies and biological evaluation
Jiongjia Cheng, Junlong Zhou, Lingyan Kong, et al.
RSC Medicinal Chemistry (2023) Vol. 14, Iss. 12, pp. 2496-2508
Closed Access | Times Cited: 17
Cytotoxicity of Pyrazine-Based Cyclometalated (C^Npz^C)Au(III) Carbene Complexes: Impact of the Nature of the Ancillary Ligand on the Biological Properties
Benoı̂t Bertrand, Julio Fernández‐Cestau, Jesús Angulo, et al.
Inorganic Chemistry (2017) Vol. 56, Iss. 10, pp. 5728-5740
Open Access | Times Cited: 59
The Trafficking of the Water Channel Aquaporin-2 in Renal Principal Cells—a Potential Target for Pharmacological Intervention in Cardiovascular Diseases
Tanja Vukićević, Maike Schulz, Dörte Faust, et al.
Frontiers in Pharmacology (2016) Vol. 7
Open Access | Times Cited: 54
Page 1 - Next Page

Scroll to top